Beng H. Chong

18.6k total citations · 3 hit papers
211 papers, 11.1k citations indexed

About

Beng H. Chong is a scholar working on Hematology, Surgery and Internal Medicine. According to data from OpenAlex, Beng H. Chong has authored 211 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Hematology, 68 papers in Surgery and 44 papers in Internal Medicine. Recurrent topics in Beng H. Chong's work include Platelet Disorders and Treatments (114 papers), Heparin-Induced Thrombocytopenia and Thrombosis (62 papers) and Venous Thromboembolism Diagnosis and Management (44 papers). Beng H. Chong is often cited by papers focused on Platelet Disorders and Treatments (114 papers), Heparin-Induced Thrombocytopenia and Thrombosis (62 papers) and Venous Thromboembolism Diagnosis and Management (44 papers). Beng H. Chong collaborates with scholars based in Australia, China and United States. Beng H. Chong's co-authors include Theodore E. Warkentin, Colin N. Chesterman, José Perdomo, Janette K. Burgess, Francesco Rodeghiero, Andreas Greinacher, Douglas B. Cines, Boban Markovic, Michael C. Berndt and P.A. Castaldi and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Beng H. Chong

206 papers receiving 10.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

2008 1.9k citations Francesco Rodeghiero, Beng H. Chong et al. Blood profile →
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia

2018 411 citations Adam Cuker, Beng H. Chong et al. Blood Advances profile →
Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia

2019 302 citations José Perdomo, Halina Leung et al. Nature Communications profile →

Peers

Countries citing papers authored by Beng H. Chong

Since Specialization

Citations

This map shows the geographic impact of Beng H. Chong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beng H. Chong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beng H. Chong more than expected).

Fields of papers citing papers by Beng H. Chong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beng H. Chong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beng H. Chong. The network helps show where Beng H. Chong may publish in the future.

Co-authorship network of co-authors of Beng H. Chong

This figure shows the co-authorship network connecting the top 25 collaborators of Beng H. Chong. A scholar is included among the top collaborators of Beng H. Chong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beng H. Chong. Beng H. Chong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments 2024 ·Blood Advances ·Halina Leung, Zohra Ahmadi, Brendan Lee, John Casey, (unknown), Steven E. McKenzie, José Perdomo, Beng H. Chong	3
2	Determination of Antibody Activity by Platelet Aggregation 2023 ·BIO-PROTOCOL ·Halina Leung, José Perdomo, Zohra Ahmadi, Beng H. Chong	1
3	NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia 2022 ·Nature Communications ·Halina Leung, José Perdomo, Zohra Ahmadi, (unknown), (unknown), Anoop Enjeti, Stephen B. Ting, James J.H. Chong, Beng H. Chong	62
4	Inhibition of NADPH oxidase blocks NETosis and reduces thrombosis in heparin-induced thrombocytopenia 2021 ·Blood Advances ·Halina Leung, José Perdomo, Zohra Ahmadi, Yan Feng, Steven E. McKenzie, Beng H. Chong	31
5	Indirect detection of anti-platelet antibodies in immune thrombocytopenia 2021 ·Pathology ·(unknown), José Perdomo, Zohra Ahmadi, Beng H. Chong	1
6	Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses 2020 ·Blood Advances ·Rebecca L. Morgan, Vahid Ashoorion, Adam Cuker, Housne Begum, Stephanie Ross, (unknown), Beng H. Chong, Lori Ann Linkins, Theodore E. Warkentin, Wojtek Wiercioch, Robby Nieuwlaat, Holger J. Schünemann, Nancy Santesso	14
7	Evolving concepts of pathogenesis of heparin‐induced thrombocytopenia: Diagnostic and therapeutic implications 2020 ·International Journal of Laboratory Hematology ·Beng H. Chong	15
8	Effect of astragalus polysaccharide on Hematopoiesis and Thrombopoiesis In Vivo and In Vitro 2017 ·Blood ·Mo Yang, (unknown), Suyi Li, Beng H. Chong, Chunfu Li	1
9	International ITP Registry with Focus on the Asia Pacific Region: Update on Preliminary Findings of Epidemiological and Clinical Data 2017 ·Blood ·Beng H. Chong, Jong‐Wook Lee, Jun Ho Jang, Tzeon‐Jye Chiou, Lai Heng Lee, Osman İlhan, Pantep Angchaisuksiri, (unknown), (unknown), Shinichiro Okamoto, (unknown), Sarah Davidson	1
10	ITP Patients in the Asia Pacific: Are They Different? 2017 ·Blood ·Beng H. Chong, Jong‐Wook Lee, Jun Ho Jang, Tzeon‐Jye Chiou, Lai Heng Lee, Osman İlhan, Pantep Angchaisuksiri, (unknown), (unknown), (unknown), Shinichiro Okamoto, Sarah Davidson	0
11	Comparison of the Effects of the Thrombopoietin (TPO) Receptor Agonist Romiplostim in Patients with Immune Thrombocytopenia (ITP) for ≤1 Year Vs. >1 Year 2017 ·Blood ·David J. Kuter, Adrian C. Newland, Beng H. Chong, Francesco Rodeghiero, (unknown), Ingrid Pabinger, Yuqi Chen, Kejia Wang, Bhakti Mehta, Melissa Eisen	1
12	Pro-Inflammatory Cytokine IL-1b on Megakaryopoiesis: A Possible Explanation of Thrombocytosis in Inflammation 2017 ·Blood ·Mo Yang, Suyi Li, Xin Zhang, Rui Cao, Chunfu Li, Beng H. Chong	2
13	Expression and functional roles of estrogen receptor GPR30 in human intervertebral disc 2016 ·The Journal of Steroid Biochemistry and Molecular Biology ·Ai‐Qun Wei, Bojiang Shen, Lisa A. Williams, (unknown), Yan Feng, Beng H. Chong, Ashish D. Diwan	20
14	Recommendations for the use of the non‐obese diabetic/severe combined immunodeficiency mouse model in autoimmune and drug‐induced thrombocytopenia: communication from the SSC of the ISTH 2015 ·Journal of Thrombosis and Haemostasis ·(unknown), Jens C. Fuhrmann, Beng H. Chong, Daniel W. Bougie, Richard H. Aster	9
15	Platelets and P-Selectin Control Tumor Cell Metastasis in an Organ-Specific Manner and Independently of NK Cells 2012 ·Cancer Research ·Lucy A. Coupland, Beng H. Chong, Christopher R. Parish	146
16	Platelet-derived growth factor enhances platelet recovery in a murine model of radiation-induced thrombocytopenia and reduces apoptosis in megakaryocytes via its receptors and the PI3-k/Akt pathway 2010 ·Haematologica ·(unknown), Godfrey Chi Fung Chan, Liang Qiao, Qizhou Lian, Fan‐Yi Meng, Xiaobing Luo, Levon M. Khachigian, Ming Ma, Rong Deng, Jianliang Chen, Beng H. Chong, Mo Yang	38
17	Once-Daily Enoxaparin in The Outpatient Setting Versus Unfractionated Heparin in Hospital for the Treatment of Symptomatic Deep-Vein Thrombosis 2005 ·Journal of Thrombosis and Thrombolysis ·Beng H. Chong, Tim Brighton, Ross Baker, Peter J. Thurlow, (unknown), (unknown)	39
18	Protein-Protein Interaction between Fli-1 and GATA-1 Mediates Synergistic Expression of Megakaryocyte-Specific Genes through Cooperative DNA Binding 2004 ·Molecular and Cellular Biology ·Michael Eisbacher, Melissa L. Holmes, Anthea Newton, Philip J. Hogg, Levon M. Khachigian, Merlin Crossley, Beng H. Chong	7
19	Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia 2002 ·Annals of Oncology ·Mark Rosenthal, Danny Rischin, Grant A. McArthur, Karen Ribbons, Beng H. Chong, Jawed Fareed, Guy C. Toner, M. D. Green, R. Basser	47
20	Heparin‐induced thrombocytopenia and thrombosis syndrome: in vivo cross‐reactivity with danaparoid and successful treatment with r‐Hirudin 2001 ·British Journal of Haematology ·(unknown), Beng H. Chong	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact